Signaling pathways involved in p38-ERK and inflammatory factors mediated the anti-fibrosis effect of AD-2 on thioacetamide-induced liver injury in mice.
暂无分享,去创建一个
J. Nan | Yan-ling Wu | Yuqing Zhao | Rui Wang | G. Su | Zhi-yao Li | Ye-Zhi Lu | Ji-Xing Nan
[1] Mohamed N Abdelnabi,et al. Type 3 cytokines in liver fibrosis and liver cancer. , 2019, Cytokine.
[2] R. Fiorotto,et al. Animal models for cystic fibrosis liver disease (CFLD). , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[3] Zhi Liu,et al. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway. , 2019, Journal of agricultural and food chemistry.
[4] A. El-Karef,et al. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. , 2018, Chemico-biological interactions.
[5] K. Kuča,et al. Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[6] Wei Zhang,et al. Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[7] D. Schuppan,et al. Liver fibrosis: Direct antifibrotic agents and targeted therapies. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[8] I. Sagi,et al. The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery. , 2018, Advanced drug delivery reviews.
[9] A. Feldstein,et al. Inflammasomes in Liver Fibrosis , 2017, Seminars in Liver Disease.
[10] Q. Yuan,et al. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] Qingxi Chen,et al. Protective effect of a polysaccharide from Anoectochilus roxburghii against carbon tetrachloride-induced acute liver injury in mice. , 2017, Journal of ethnopharmacology.
[12] Rui-sheng Li,et al. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways. , 2016, International immunopharmacology.
[13] V. Lagente,et al. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis , 2016, Bioscience reports.
[14] A. Gerbes,et al. Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model. , 2016, World journal of hepatology.
[15] F. Jorquera,et al. P0720 : Improvement of advanced liver fibrosis and regression of liver cirrhosis in patients with hepatitis C genotype 1 after HCV protease inhibitor-based triple therapy , 2015 .
[16] Don C Rockey,et al. Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.
[17] Jie Fan,et al. Anti-fibrotic effect of thymoquinone on hepatic stellate cells. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[18] E. Kouroumalis,et al. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells , 2014, Regulatory Peptides.
[19] D. Vecchio,et al. Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells. , 2013, Free radical biology & medicine.
[20] T. Saibara,et al. Tumor Necrosis Factor-α Promotes Cholestasis-Induced Liver Fibrosis in the Mouse through Tissue Inhibitor of Metalloproteinase-1 Production in Hepatic Stellate Cells , 2013, PloS one.
[21] S. Sakr,et al. Histological and histochemical alterations in liver of chronic hepatitis C patients with Helicobacter pylori infection. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[22] Feng Zhang,et al. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways. , 2012, Toxicology and applied pharmacology.
[23] W. Wahli,et al. GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation , 2012, Cell & Bioscience.
[24] S. Friedman,et al. Antifibrotic Activity of Sorafenib in Experimental Hepatic Fibrosis: Refinement of Inhibitory Targets, Dosing, and Window of Efficacy In Vivo , 2012, Digestive Diseases and Sciences.
[25] J. Nan,et al. 25-OCH3-PPD induces the apoptosis of activated t-HSC/Cl-6 cells via c-FLIP-mediated NF-κB activation. , 2011, Chemico-biological interactions.
[26] K. Doi,et al. Changes in TIMP-1 and -2 expression in the early stage of porcine serum-induced liver fibrosis in rats. , 2011, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[27] D. Bar-Sagi,et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. , 2009, The Journal of clinical investigation.
[28] Ling Zhou,et al. Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1 , 2009, BMC Immunology.
[29] J. Tschopp,et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis , 2008 .
[30] S. Friedman,et al. Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.
[31] Detlef Schuppan,et al. Liver cirrhosis , 2008, The Lancet.
[32] S. Akira,et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. , 2007, The Journal of clinical investigation.
[33] Ling-tai Wang,et al. Upregulation of TNF-α mRNA in hepatic fibrosis rats induced by dimethylnitrosamine , 2007 .
[34] W. Zeng,et al. Effects of extracellular signal‐regulated kinase on rat cultured hepatic stellate cells stimulated by acetaldehyde , 2007, Journal of digestive diseases.
[35] H. Ichijo,et al. Stress-responsive protein kinases in redox-regulated apoptosis signaling. , 2005, Antioxidants & redox signaling.
[36] S. Terai,et al. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. , 2003, Journal of hepatology.
[37] D. Brenner,et al. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells , 2001, Hepatology.
[38] H. Reeves,et al. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. , 2000, Journal of hepatology.
[39] M. Buck,et al. Long- and short-termd-α-tocopherol supplementation inhibits liver collagen α1(Ι) gene expression. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[40] I. Hernández-Muñoz,et al. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. , 1997, Gastroenterology.
[41] D. Schuppan,et al. Structure of the Extracellular Matrix in Normal and Fibrotic Liver: Collagens and Glycoproteins , 1990, Seminars in liver disease.
[42] A. Yang,et al. Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs/TIMPs system in rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[43] Jong Joon Lee,et al. Molecular Mechanisms Elucidating Why Old Stomach Is More Vulnerable to Indomethacin-Induced Damage than Young Stomach , 2012, Digestive Diseases and Sciences.
[44] O. Dirsch,et al. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats. , 2012, Cytokine.
[45] R. Schwabe,et al. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. , 2010, Gastroenterology.